What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News Activation of different genes would explain the higher severity of acute kidney injury in males than in females Researchers have generated a female and male pig model of ischemia/reperfusion renal injury and organ regeneration to study sex differences in gene activation and molecular processes. Activities Curso Exoma Más información: https://aula.vallhebron.com/aula/index.php?go=info_cursos&curso=428&idioma=en Aula Vall d’Hebron Mail: inscripcionsaulavh@vhebron.net Tel: 93 489 45 68 News A publication of Vall d'Hebron, awarded by 'Anales de Pediatría' for being the most cited of the journal in the last two years The work was one of the first to identify skin lesions associated with SARS-CoV-2 infection in children at the beginning of the pandemic. News Two studies by the VHIR Child Cancer and Blood Disorders Group to be presented at the ASCO Congress These studies, part of the BEACON project, describe the efficacy of a new immunotherapy treatment for neuroblastoma and the usefulness of new biomarkers in predicting the prognosis and response to therapy. News Identified a biomarker that predicts long-term impairment in progressive multiple sclerosis patients The study conducted at Vall d'Hebron shows that having a high level of neurofilament light chains translates, over the years, to a higher level of disability. News The European Association of Pediatric Infectious Diseases has awarded a study in which Vall d'Hebron has participated The article on the mortality rate of young people with HIV due to perinatal transmission after transitioning to adult health care in Spain received the PIDJ award. News Identified one of the mechanisms that cause neuronal damage in patients with multiple sclerosis The research led by Vall d'Hebron is a breakthrough in the search for specific and effective treatments for the disease. News VHIR Annual Report 2021 We present VHIR's annual commitment to communicate the scientific and institutional results of 2021 with a renewed format and design. News New drug could improve response to cancer treatments The drug EB1, studied by researchers at Vall d'Hebron and IQS-Universitat Ramon Llull, is able to block resistance pathways to standard cancer treatments and could increase the efficacy of chemotherapy or immunotherapy. News The Catalan government awards the Narcís Monturiol Plaque to the VHIR for its contribution to the development of science and technology This award is given to people and organisations in recognition of outstanding contributions to the development of science and technology in Catalonia. Pagination Previous page ‹‹ Page 114 Next page ››